[Immunoexpression of c-erbB-2 in intraductal proliferative lesions of the female breast].

Objectives: Genetic modifications are related to genesis and development of cancer. Neoplasias in various organs express the c-erbB-2 oncogene. In intraductal proliferations of the breast it has been assessed as a risk factor for subsequent development of carcinoma.